More recently, ALK rearrangements have been implicated in a variety of tumor types, notably non-small cell lung carcinoma (NSCLC), inflammatory myofibroblastic tumors (IMT), and renal cancer [4]. The gene discussed is ALK; the disease is inflammatory myofibroblastic tumor.